Search results

Membership details, terms of reference and future meeting dates for our quality standards advisory committee.

Our HealthTech Programme evaluates new HealthTech.

Find out which guidance and quality standards are awaiting development

See a complete list of all our guidance and quality standards currently open for consultation

NICE's guidance executive is made up of executive directors, guidance centre directors and senior team members.

Day-to-day decision making is the responsibility of NICE's executive team.

Our board sets out our strategic priorities and policies. It has 2 sub-committees, the audit and risk assurance committee and the remuneration committee.

With around 2 million healthtech products registered for UK use, differentiating your innovation from the competition is vital. A NICE recommendation helps you cut through the noise, demonstrate your product’s value and smooth your path to market.

Page 1 of 11 Taking tamoxifen to reduce the chance of developing breast cancer Decision aid for premenopausal women at high risk Published

Sole supplied titles are distinct journal and book collections that can be purchased from Lot 1 of our purchasing framework.

Find out what guidance is being considered for development

Browse the complete list of all our published health and social care guidance, including guidelines, NICE advice and quality standards

NICE Advice - a fee-based advisory service for pharmaceutical and healthtech companies seeking to enter the NHS market,

NICE Advice works closely with our system partners and industry to drive innovation into the hands of health and care professionals, to enable best practice.

Evidence-based recommendations on epidermal radiotherapy using rhenium-188 paste for non-melanoma skin cancer. This involves radioactive paste being spread on foil over the top of the cancer, to destroy the cancer cells.

Result type

HealthTech guidance

Published

2 April 2024